Furthermore, the PNPLA3 variant also predisposes to HCC in other liver diseases associated with steatosis, namely alcoholic liver disease (ALD) and chronic hepatitis C (CHC)23. Here, PNPLA3 is linked to hepatocellular carcinoma.